Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

MEI Pharma launched a $100 million Litecoin treasury strategy with backing from GSR, Titan Partners, and the Litecoin Foundation. Litecoin creator Charlie Lee joined MEI’s board, marking a rare ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging with institutional interest and ...

MEI Pharma (MEIP) shares soared Friday premarket as it unveiled a $100 million private placement to fund its new Litecoin treasury strategy, marking a groundbreaking shift in corporate crypto ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a Litecoin treasury strategy, marking it ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...